Stryker Corporation has launched its next-generation InThrill Thrombectomy System, a medical device designed to improve treatment of small vessel and arteriovenous thrombosis.

Stryker Corp has secured FDA clearance for its OptaBlate BVN System, bolstering its market position and maintaining its strong valuation in the medical technology industry.